Drug intelligence / Profile preview

LyoPlas

Development stage
Unknown
Lead developer
DRK-Blutspendedienst West
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Intravenous
01

Overview

LyoPlas is a freeze-dried (lyophilized) human plasma product used for transfusion, primarily in the management of major trauma, severe bleeding, and coagulopathies. It is produced from single donors and contains all coagulation factors, fibrinolytic proteins, their inhibitors, and other plasma proteins at levels similar to those found in fresh frozen plasma (FFP). The product undergoes pathogen reduction processes such as solvent/detergent treatment to enhance safety. After donation, the plasma is quarantined for at least four months and only released after repeated negative donor tests[1][9]. Lyophilization allows storage at room temperature for extended periods (up to 24 months), rapid reconstitution with sterile water within minutes, and use in prehospital or austere environments where conventional FFP storage is impractical[2][6]. Clinical studies have shown that its hemostatic efficacy is comparable to FFP when used as part of massive transfusion protocols. It has an excellent safety record with adverse reaction rates similar to FFP[6][7].

Brand names
LyoPlasLyoPlas N-w
Other names
freeze-dried plasmalyophilized plasmaFDP (freeze-dried plasma)

Beyond the preview

Go deeper on LyoPlas.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LyoPlas.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call